Published in Gene Therapy Weekly, March 1st, 1999
J.K. Schroder and colleagues from the University of Essen, Germany, investigated the role of CDD in AML ("Structural and Functional Analysis of the Cytidine Deaminase Gene in Patients with Acute Myeloid Leukaemia," British Journal of Haematology, December 1998;103(4):1096-1103).
"Gene transfer of the cytidine deaminase (CDD) cDNA has recently been shown to induce cellular resistance to cytarabine (AraC) in vitro," wrote Schroder et al. "To investigate the role for CDD in acute myeloid leukaemia (AML), we analyzed the CDD...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.